Ito et al reported a risk score for patients undergoing percutaneous coronary intervention with drug-eluting stent placement. The authors are participants in the STENT (Strategic Transcatheter Evaluation of New Therapies) group from multiple hospitals in the United States.
Patient selection: percutaneous coronary intervention (PCI) with placement of a drug-eluting stent (DES)
Outcome: major adverse cardiac or cerebrovascular event (MACCE) within 30 days
Parameters:
(1) cardiogenic shock
(2) acute congestive heart failure
(3) pre-procedural statin use
(4) hemoglobin in g.dL
(5) left main coronary artery disease
(6) left anterior descending (LAD) coronary artery diseaes
(7) ostial lesion
(8) ACC/AHA type C lesion
(9) coronary artery thrombosis
|
Parameter |
Finding |
Points |
|
cardiogenic shock |
no |
0 |
|
|
yes |
9 |
|
acute congestive heart failure |
no |
0 |
|
|
yes |
3 |
|
pre-procedural statin |
no |
1 |
|
|
yes |
0 |
|
hemoglobin |
< 9 g/dL |
5 |
|
|
9 to 9.9 g/dL |
4 |
|
|
10 to 10.9 g/dL |
3 |
|
|
11 to 11.9 g/dL |
2 |
|
|
12 to 12.9 g/dL |
1 |
|
|
13 to 13.9 g/dL |
0 |
|
|
14 to 14.9 g/dL |
-1 |
|
|
>= 15 g/dL |
-2 |
|
left main CAD |
no |
0 |
|
|
yes |
5 |
|
left anterior descending CAD |
no |
0 |
|
|
yes |
1 |
|
ostial lesion |
no |
0 |
|
|
yes |
3 |
|
type C lesion |
no |
0 |
|
|
yes |
2 |
|
coronary thrombosis |
no |
0 |
|
|
yes |
4 |
total score =
= SUM(points for all 9 parameters)
Interpretation:
• minimum score: -2
• maximum score: 33
• The higher the score the greater the risk for a major adverse event.
|
Score |
Risk of a Major Adverse Event |
|
-2 to 16 |
(0.07519 * ((score)^2)) + (0.6917 * (score)) + 1.43 |
|
16 to 26 |
(3.939 * (score)) – 41.59 |
|
26 to 33 |
(-0.07679 * ((score)^2)) + (7.835 * (score)) – 90.69 |
Specialty: Cardiology
ICD-10: ,
